Publication Lepromatous leprosy infection from Mycobacterium lepromatosis without known risk factors or exposures in the Upper Midwest United States. Fleischmann H, Sureshkumar N, Stratman E. JAAD case reports. 2024; Download PDF
Publication Sequential occurrence of upgrading and downgrading type 1 leprosy reactions: A case report. Sharath S, Sinha S, Sardana K, et al. Tropical doctor. 2024;
Publication A case of lepromatous leprosy in Arizona, United States. Robbins K, Luna-Wong L, Adams M, et al. JAAD case reports. 2024; Download PDF
Publication Leprosy in a Patient With Lymphoma: A Challenge in the Twenty-First Century Antunes E, Araújo IM, Cubal F, et al. Springer Science and Business Media LLC. Cureus. 2023; Download PDF
Publication Assessment of knowledge and awareness about leprosy among medical college students in Tripoli Amer H, Hariba Z. Journal of Science and Technology - Awlad Ali. 2023; Download PDF
Publication Use of Multidrug Therapy Regimen for Hansen Disease Patients Nawaz S. Mycobacterial Diseases. 2023; 13 (5) : 1. Download PDF
Publication Increscent journey of anti-leprosy drug development. Gautam S, Sharma D, Singh S, et al. Current Science. 2023; 125 (3) : 253-267. Download PDF
Publication Reações adversas aos medicamentos de dois esquemas de tratamento da hanseníase em um Centro de Referência Nacional do Brasil Celestino I. EDUFU - Editora da Universidade Federal de Uberlandia. 2023;
Publication Rifapentine in Household Contacts of Patients with Leprosy. Yotsu R, Bedimo R. The New England journal of medicine. 2023; 389 (7) : 672-673.
Publication Rifapentine in Household Contacts of Patients with Leprosy. Reply. Wang L, Xiong J, Wang H. The New England journal of medicine. 2023; 389 (7) : 673.
Publication Leprosy in the Upper Midwest. Bach K, Hinshaw M, Shields B. Wisconsin Medical Journal. 2023; 122 (3) : 205-207. Download PDF
Publication Scenarios warranting modified treatment regimens in leprosy: A 5-year retrospective study from a tertiary care center Hamlet C, Nair PS. Scientific Scholar. Journal of Skin and Sexually Transmitted Diseases. 2023; Download PDF
Publication Leprosy, the Great Imitator of Rheumatic Diseases: A Case Study Youssef H, Mahani T, Hojjati M. Springer Science and Business Media LLC. Cureus. 2023; Download PDF
Publication A Current Perspective on Leprosy (Hansen’s Disease) Borah Slater K. Springer International Publishing. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. 2023; Download PDF
Publication The perennial pursuit for an ideal anti-leprosy treatment Dogra S, Narang T, Mehta H, et al. Lepra. Leprosy Review. 2023; 94 (1) : 89-92. Download PDF
Publication Novel approaches in the treatment of Hansen’s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States Franco-Paredes C, Garcia-Creighton E, Henao-Martínez A, et al. SAGE Publications. Therapeutic Advances in Infectious Disease. 2022; Download PDF
Publication Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme. Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022; Download PDF
Publication Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India. Lavania M, Darlong J, Singh I, et al. Journal of global antimicrobial resistance. 2020; Download PDF
Publication Treatment of histoid leprosy: a lack of consensus. Bartos G, Sheuring R, Combs A, et al. International journal of dermatology. 2020;
Publication Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports Widjaja Y, Djawad K, Amin S, et al. Walter de Gruyter GmbH. Serbian Journal of Dermatology and Venereology. 2019; 11 (3) : 89-93. Download PDF